Dr. Arslan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 Duarte Rd
Bradbury, CA 91010Phone+1 626-256-4673
Summary
- Dr. Shukaib Arslan is a specialized healthcare provider in Hematology with a subspecialty in Hematologic Oncology, based in Duarte, CA. He gained comprehensive experience in his field through his education at different medical institutions, including King Edward Medical University and City of Hope National Medical Center, where he completed a fellowship in Blood & Bone Marrow Transplant. He is currently serving as an Assistant Clinical Professor at City of Hope. Dr. Arslan has contributed a variety of scholarly articles to the medical field, indicating his active participation in research. His work is published in notable journals such as Transplantation and Cellular Therapy, Cureus, and Cancer Medicine.
Education & Training
City of Hope National Medical CenterFellowship, Blood & Bone Marrow Transplant, 2018 - 2019
Ascension Providence/MSUCHMFellowship, Hematology and Medical Oncology, 2015 - 2018
Detroit Medical Center/Wayne State UniversityResidency, Internal Medicine, 2010 - 2013
King Edward Medical UniversityClass of 2007
Certifications & Licensure
TX State Medical License 2024 - 2026
CA State Medical License 2018 - 2025
MI State Medical License 2010 - 2020
MA State Medical License 2016 - 2016
AR State Medical License 2014 - 2015
Publications & Presentations
PubMed
- 7 citationsClinical experience with venetoclax and hypomethylating agents (HMA) in patients with newly diagnosed and relapsed or refractory KMT2A-Rearranged acute myeloid leukemi...Brian J Ball, Shukaib Arslan, Paul Koller, Dat Ngo, Michelle Afkhami
Leukemia & Lymphoma. 2022-12-01 - 38 citationsPosttransplant cyclophosphamide as GVHD prophylaxis for peripheral blood stem cell HLA-mismatched unrelated donor transplantMonzr M. Al Malki, Ni-Chun Tsai, Joycelynne Palmer, Sally Mokhtari, Weimin Tsai
Blood Advances. 2021-06-22 - 25 citationsExtramedullary disease relapse and progression after blinatumomab therapy for treatment of acute lymphoblastic leukemiaIbrahim Aldoss, Salman Otoukesh, Jianying Zhang, Sally Mokhtari, Dat Ngo
Cancer. 2021-10-11
Abstracts/Posters
- Real World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated with Inotuzumab OzogamicinShukaib Arslan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Real World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated with BlinatumomabShukaib Arslan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Optimization of Tacrolimus Serum Levels When Combined with Post-Transplant Cyclophosphamide As Graft-Versus-Host Disease Prophylaxis after Hematopoietic Cell Transplan...Shukaib Arslan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
